Evidence map›Paper›PMID 41938435›Full record

ArticleInternational journal of surgery case reports2026

Recurrent pancreatic acinar cell carcinoma following a 7-year disease-free interval: A case report and literature review.

Chorouq Mehdaoui, Abdelkrim Zazour, Anass Haloui, Imane Kamaoui, Ghizlane Kharrasse, Zahi Ismaili

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chorouq MehdaouiDepartment of Hepatogastroenterology, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Morocco.
Abdelkrim ZazourDepartment of Hepatogastroenterology, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Morocco.
Anass HalouiPathology Department, Mohammed VI University Hospital, Oujda, Morocco. Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Morocco.
Imane KamaouiDepartment of Radiology, Mohammed VI University Hospital Center, Medical Sciences Research Laboratory. Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Morocco.
Ghizlane KharrasseDepartment of Hepatogastroenterology, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Morocco.
Zahi IsmailiDepartment of Hepatogastroenterology, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy of Oujda, Mohammed First University of Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Pancreatic acinar cell carcinoma (PACC) is a rare malignant pancreatic tumor, accounting for only 1% of all pancreatic neoplasms. It has distinctive clinical, radiological, and histological features. Case presentation: Here, we report a case of PACC diagnosed 7 years after surgical treatment for pancreatic ductal adenocarcinoma (PDAC). The recurrence was suspected during routine follow-up via abdominal computed tomography scan, which showed a local mass without biliary ducts dilation, vascular involvement, or any specific radiological signs. However, clinical examination and laboratory workup, including tumor markers (CA 19-9 and carcinoembryonic antigen), were normal. By comparing samples obtained via endoscopic ultrasound fine-needle aspiration of the pancreatic mass to the histopathological findings of the prior duodenopancreatectomy, a diagnosis of local recurrence of previously misdiagnosed PACC was established. Clinical discussion: PACC is a rare pancreatic epithelial malignancy (1%), for which radical surgical resection remains the treatment of choice. However, it is usually diagnosed at an advanced stage (with metastasis). The most common differential diagnoses include pancreatic adenocarcinoma, pancreatic neuroendocrine tumors, solid pseudopapillary neoplasms, and pancreatoblastoma in the pediatric population. Histopathological examination combined with immunohistochemical staining remains the cornerstone for establishing the diagnosis. In our case, ultrasound-guided fine needle aspiration of the pancreatic mass, compared to the previous duodenopancreatectomy, led to the diagnosis of a local recurrence of a previously misdiagnosed initially as PDAC, with the longest survival (84 months) ever described in the literature. Conclusions: Due to its rarity, PACC remains a diagnostic challenge. It has a better prognosis than PDAC; radical resection is recommended.

Indexed as

case reportcytopathology and immunohistochemical stainingendoscopic ultrasound-guided fine-needle aspirationlong-term survivalpancreatic acinar cell carcinomapancreatic neoplasmsradical surgery

Identifiers

PMID41938435
PMCPMC13046000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.